“Time Is Muscle” in Acute Heart Failure: Critical Concept or Fake News?

JACC: Heart Failure

Volumn 6, Issue 4, 2018, Pages 295-297

  Felker, G Michael ^a   Januzzi, James L ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute heart failure; heart failure; time to treatment

Indexed keywords

ACUTE HEART FAILURE; ARTIFICIAL VENTILATION; EDITORIAL; GOLD STANDARD; HOSPITAL DISCHARGE; HUMAN; LUNG EDEMA; LUNG EMBOLISM; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PNEUMONIA; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROPENSITY SCORE; ST SEGMENT ELEVATION; THORAX RADIOGRAPHY; UNITED STATES; HEART FAILURE;

DIURETIC AGENT;

DIURETICS; HEART FAILURE; HUMANS;

EID: 85044008530     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2018.01.011     Document Type: Editorial

References (8)

1. Cannon, C.P., Gibson, C., Lambrew, C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000), 2941–2947.
2. Packer, M., O'Connor, C., McMurray, J.J.V., et al. Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med 376 (2017), 1956–1964.
3. Teerlink JR, Metra M. Serelaxin in acute heart failure: results of the RELAX-AHF-2 Trial. Paper presented at: Heart Failure Association of the ESC; Paris, France; 2017.
4. Januzzi, J.L. Jr., Felker, G.M., Door-to-furosemide therapy in the ED: New quality metric or just a piece of the puzzle?. J Am Coll Cardiol 69 (2017), 3052–3054.
5. Matsue, Y., Damman, K., Voors, A.A., et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol 69 (2017), 3042–3051.
6. Park, J.J., Kim, S.-H., Oh, I.-Y., et al. The effect of door-to-diuretic time on clinical outcomes in acute heart failure patients. J Am Coll Cardiol HF 6 (2018), 286–294.
7. Maisel, A.S., Peacock, W.F., McMullin, N., et al. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 52 (2008), 534–540.
8. Wong, Y.W., Mentz, R.J., Felker, G.M., et al. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. Eur J Heart Fail 18 (2016), 684–692.